Advertisement
Advertisement
NBP
N
NovaBridge Biosciences - ADR
2.55
USDSponsored
-0.08
-3.22%
Mar 26, 15:58 UTC -4
Closed
Pre-Market
2.60
+0.05
+2.08%
NBP Earnings Reports
Positive Surprise Ratio
NBP beat 3 of 6 last estimates.
50%
Next Report
Next Week
Date of Next Report
Apr 01, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.05
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 24 (Revenue/ EPS)
--
/-37.50%
NovaBridge Biosciences - ADR earnings per share and revenue
On --, NBP reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, 7 analysts forecast an EPS of -0.05 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Candel Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.25
Actual
-$0.54
Surprise
-115.31%
Acumen Pharmaceuticals, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.46
Actual
-$0.41
Surprise
+11.29%
Rani Therapeutics Holdings, Inc. Class A Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.07
Surprise
-2.94%
Spero Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.20
Actual
$0.53
Surprise
+359.80%
Alpha Cognition Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.27
Actual
-$0.30
Surprise
-8.93%
Cognition Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.02
Surprise
+76.47%
Celcuity Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.06
Actual
-$0.97
Surprise
+8.72%
Dyadic International, Inc.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.06
Surprise
-30.72%
Quantum Biopharma Ltd. Class B Subordinate Voting Shares
Report Date
Mar 26, 2026 For Q4 25
Estimate
-Actual
-$0.71
Surprise
-
CollPlant Biotechnologies Ltd Ordinary Shares
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.67
Surprise
-245.72%
FAQ
What were NovaBridge Biosciences - ADR's earnings and revenue for the latest quarter Q-- --?
For Q-- --, NovaBridge Biosciences - ADR reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to NovaBridge Biosciences - ADR's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is NovaBridge Biosciences - ADR expected to report next?
The next earning report is scheduled for Apr 01, 2026.
What are the forecasts for NovaBridge Biosciences - ADR's next earnings report?
Based on 7
analysts, NovaBridge Biosciences - ADR is expected to report EPS of -$0.05 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement